McMillan Office’s Chemed CHE Stock Holding History

McMillan Office’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$186K	Hold	400	–	–	0.02%	191
2026 Q1	$151K	Hold	400	–	–	0.02%	201
2025 Q4	$171K	Buy	+400	New	+$174K	0.02%	195

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

McMillan Office's CHE Position: Q2 2026 in Review

McMillan Office held its Chemed (CHE) position steady in Q2 2026 at 400 shares worth $186K. The position accounts for 0.02% of the portfolio, ranked #191.

McMillan Office first reported a position in CHE in Q4 2025 and has held it in 3 quarters since. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

McMillan Office held 400 shares of Chemed worth $186K as of Q2 2026.
McMillan Office left its Chemed share count unchanged in Q2 2026.
Chemed made up 0.02% of McMillan Office's portfolio in Q2 2026, its #191 holding.
McMillan Office first reported a position in Chemed in Q4 2025 and has held it in 3 quarters since.
532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.